These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10818763)

  • 1. Calpastatin (the endogenous calpain inhibitor) and membrane protein degradation in cell fusion.
    Kosower NS; Barnoy S
    Methods Mol Biol; 2000; 144():181-94. PubMed ID: 10818763
    [No Abstract]   [Full Text] [Related]  

  • 2. Calpains and myogenesis.
    Cottin P; Poussard S; Dargelos E; Balcerzak D; Aragon B; Brustis JJ; Ducastaing A
    Methods Mol Biol; 2000; 144():173-80. PubMed ID: 10818762
    [No Abstract]   [Full Text] [Related]  

  • 3. The calpain-calpastatin system and protein degradation in fusing myoblasts.
    Barnoy S; Glaser T; Kosower NS
    Biochim Biophys Acta; 1998 Mar; 1402(1):52-60. PubMed ID: 9551085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion.
    Barnoy S; Glasner T; Kosower NS
    Biochem Biophys Res Commun; 1996 Mar; 220(3):933-8. PubMed ID: 8607870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between catalytically inactive calpain and calpastatin. Evidence for its occurrence in stimulated cells.
    Averna M; Stifanese R; De Tullio R; Defranchi E; Salamino F; Melloni E; Pontremoli S
    FEBS J; 2006 Apr; 273(8):1660-8. PubMed ID: 16623703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of calpastatin inhibits L8 myoblast fusion.
    Barnoy S; Maki M; Kosower NS
    Biochem Biophys Res Commun; 2005 Jul; 332(3):697-701. PubMed ID: 15904894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoblast fusion requires fibronectin degradation by exteriorized m-calpain.
    Dourdin N; Brustis JJ; Balcerzak D; Elamrani N; Poussard S; Cottin P; Ducastaing A
    Exp Cell Res; 1997 Sep; 235(2):385-94. PubMed ID: 9299163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes.
    Dnyanmote AV; Sawant SP; Lock EA; Latendresse JR; Warbritton AA; Mehendale HM
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):146-57. PubMed ID: 16546232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor.
    Nakamura Y; Fukiage C; Ma H; Shih M; Azuma M; Shearer TR
    Exp Eye Res; 1999 Aug; 69(2):155-62. PubMed ID: 10433852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpastatin-modulation of m-calpain activity is required for myoblast fusion.
    Balcerzak D; Cottin P; Poussard S; Cucuron A; Brustis JJ; Ducastaing A
    Eur J Cell Biol; 1998 Mar; 75(3):247-53. PubMed ID: 9587056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calpain and calpastatin in the catabolism of erythrocyte-membrane proteins during anaemia in hamsters (Mesocricetus auretus) infected with Leishmania donovani.
    Sen G; Ghosal J; Biswas T
    Ann Trop Med Parasitol; 2002 Dec; 96(8):787-96. PubMed ID: 12625933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of calpain and calpastatin in differentiating myoblasts: mRNA levels, protein synthesis and stability.
    Barnoy S; Supino-Rosin L; Kosower NS
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):413-20. PubMed ID: 11023827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors.
    Barnoy S; Glaser T; Kosower NS
    Biochim Biophys Acta; 1997 Sep; 1358(2):181-8. PubMed ID: 9332454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation of human platelet calpain-I.
    Ariyoshi H; Shiba E; Sakon M; Kambayashi J; Yoshida K; Kawashima S; Mori T
    Biochem Mol Biol Int; 1993 May; 30(1):63-72. PubMed ID: 8358337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpastatin in rat myoblasts: transient diminution and decreased phosphorylation depend on myogenin-directed myoblast differentiation.
    Barnoy S; Kosower NS
    Int J Biochem Cell Biol; 2007; 39(1):253-61. PubMed ID: 16997608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy.
    Kumamoto T; Ueyama H; Watanabe S; Yoshioka K; Miike T; Goll DE; Ando M; Tsuda T
    Acta Neuropathol; 1995; 89(5):399-403. PubMed ID: 7618437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and immunolocalization of the calpain-calpastatin system in the human oocyte.
    Ben-Aharon I; Ben-Yosef D; Amit A; Shalgi R
    Fertil Steril; 2005 Jun; 83(6):1807-13. PubMed ID: 15950654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E; Perez J; Bellocq A; Mesnard L; de Castro Keller A; Haymann JP; Baud L
    Circ Res; 2008 Mar; 102(6):720-8. PubMed ID: 18258859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.